Capsicum Oleoresin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11131 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | mitochondrial complex 5 (ATP synthase) deficiency nuclear | KG + DL |
| 2 | nasal alar collapse, bilateral | KG + DL |
| 3 | diaphragmatic hernia | KG + DL |
| 4 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 5 | 5-oxoprolinase deficiency (disease) | KG + DL |
| 6 | ear folding | KG + DL |
| 7 | neuropathy, hereditary sensory and autonomic, adult-onset, with anosmia | KG + DL |
| 8 | nail-patella syndrome | KG + DL |
| 9 | succinic acidemia | KG + DL |
| 10 | X-linked spermatogenic failure | KG + DL |
| 11 | corpus callosum, agenesis of | KG + DL |
| 12 | encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities | KG + DL |
| 13 | melorheostosis | KG + DL |
| 14 | visceral steatosis, congenital | KG + DL |
| 15 | autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency | KG + DL |
| 16 | adult-onset autosomal dominant demyelinating leukodystrophy | KG + DL |
| 17 | ataxia-hypogonadism-choroidal dystrophy syndrome | KG + DL |
| 18 | channelopathy-associated congenital insensitivity to pain, autosomal recessive | KG + DL |
| 19 | encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8 | KG + DL |
| 20 | coloboma, ocular | KG + DL |
| 21 | arterial tortuosity syndrome | KG + DL |
| 22 | isolated hemihyperplasia | KG + DL |
| 23 | microcytic anemia with liver iron overload | KG + DL |
| 24 | glycogen storage disease due to muscle beta-enolase deficiency | KG + DL |
| 25 | neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-hip dysplasia syndrome due to a point mutation | KG + DL |
| 26 | cranioacrofacial syndrome | KG + DL |
| 27 | Sorsby’s fundus dystrophy | KG + DL |
| 28 | pernicious anemia | KG + DL |
| 29 | pulmonary alveolar proteinosis with hypogammaglobulinemia | KG + DL |
| 30 | Lichtenstein-Knorr syndrome | KG + DL |
| 31 | pontine autosomal dominant microangiopathy with leukoencephalopathy | KG + DL |
| 32 | prominent glabella-microcephaly-hypogenitalism syndrome | KG + DL |
| 33 | pancreas, dorsal, agenesis of | KG + DL |
| 34 | hyperargininemia | KG + DL |
| 35 | otospondylomegaepiphyseal dysplasia, autosomal dominant | KG + DL |
| 36 | congenital heart block | KG + DL |
| 37 | megalencephalic leukoencephalopathy with cysts | KG + DL |
| 38 | Fibulo-ulnar hypoplasia-renal anomalies syndrome | KG + DL |
| 39 | dyschromatosis universalis hereditaria | KG + DL |
| 40 | retinoschisis, autosomal dominant | KG + DL |
| 41 | toe, rotated fifth | KG + DL |
| 42 | intellectual disability-obesity-prognathism-eye and skin anomalies syndrome | KG + DL |
| 43 | neonatal ichthyosis-sclerosing cholangitis syndrome | KG + DL |
| 44 | congenital hypothalamic hamartoma syndrome | KG + DL |
| 45 | hereditary angioedema | KG + DL |
| 46 | autosomal recessive cerebellar ataxia - epilepsy - intellectual disability syndrome due to TUD deficiency | KG + DL |
| 47 | exercise intolerance, riboflavin-responsive | KG + DL |
| 48 | Rienhoff syndrome | KG + DL |
| 49 | membranoproliferative glomerulonephritis, X-linked | KG + DL |
| 50 | oculocerebral hypopigmentation syndrome of Preus | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.